Success Metrics

Clinical Success Rate
68.0%

Based on 17 completed trials

Completion Rate
68%(17/25)
Active Trials
8(15%)
Results Posted
18%(3 trials)
Terminated
8(15%)

Phase Distribution

Ph phase_3
6
12%
Ph early_phase_1
2
4%
Ph phase_4
3
6%
Ph phase_1
7
13%
Ph phase_2
17
33%
Ph not_applicable
15
29%

Phase Distribution

9

Early Stage

17

Mid Stage

9

Late Stage

Phase Distribution50 total trials
Early Phase 1First-in-human
2(4.0%)
Phase 1Safety & dosage
7(14.0%)
Phase 2Efficacy & side effects
17(34.0%)
Phase 3Large-scale testing
6(12.0%)
Phase 4Post-market surveillance
3(6.0%)
N/ANon-phased studies
15(30.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

65.4%

17 of 26 finished

Non-Completion Rate

34.6%

9 ended early

Currently Active

8

trials recruiting

Total Trials

52

all time

Status Distribution
Active(10)
Completed(17)
Terminated(9)
Other(16)

Detailed Status

Completed17
unknown15
Terminated8
Recruiting5
Active, not recruiting3
Not yet recruiting2

Development Timeline

Analytics

Development Status

Total Trials
52
Active
8
Success Rate
68.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 12 (4.0%)
Phase 17 (14.0%)
Phase 217 (34.0%)
Phase 36 (12.0%)
Phase 43 (6.0%)
N/A15 (30.0%)

Trials by Status

completed1733%
suspended12%
unknown1529%
withdrawn12%
not_yet_recruiting24%
recruiting510%
terminated815%
active_not_recruiting36%

Recent Activity

8 active trials
Showing 5 of 52
completednot_applicable

Oxygen as a Limiting Factor for Performing Multitasking

NCT03126669
recruitingnot_applicable

Hyperbaric Oxygen Therapy for Post-COVID-19 Syndrome

NCT04647656
active_not_recruiting

Cognitive Profile of Patients at the Sagol Center for Hyperbaric Medicine and Research

NCT04287283
active_not_recruitingphase_4

Hyperbaric Oxygen Therapy for Soft Tissue Sarcoma Pilot Study

NCT03144206
terminatedphase_2

Efficacy of Hyperbaric Oxygen Therapy in the Treatment of Osteoradionecrosis

NCT00989820
View all 52 trials

Clinical Trials (52)

Showing 20 of 52 trialsScroll for more
NCT03126669Not Applicable

Oxygen as a Limiting Factor for Performing Multitasking

Completed
NCT04647656Not Applicable

Hyperbaric Oxygen Therapy for Post-COVID-19 Syndrome

Recruiting
NCT04287283

Cognitive Profile of Patients at the Sagol Center for Hyperbaric Medicine and Research

Active Not Recruiting
NCT03144206Phase 4

Hyperbaric Oxygen Therapy for Soft Tissue Sarcoma Pilot Study

Active Not Recruiting
NCT00989820Phase 2

Efficacy of Hyperbaric Oxygen Therapy in the Treatment of Osteoradionecrosis

Terminated
NCT04862676Early Phase 1

Repeated HBO Therapy in Myeloma Patients Undergoing High-Dose Therapy and Auto-HCT

Completed
NCT04717557Phase 1

Hyperbaric Oxygen and Outcome After Below Knee Amputations

Terminated
NCT03739502Phase 2

A Randomized Phase II Study of Hyperbaric Oxygen in Improving Engraftment in Umbilical Cord Blood Stem Cell Transplant

Recruiting
NCT06128720Not Applicable

Hyperbaric Oxygen Therapy for Optic Neuropathies

Recruiting
NCT03964506Early Phase 1

Hyperbaric Oxygen Therapy and Allogeneic Peripheral Blood Stem Cell (PBSC) Transplant

Recruiting
NCT06526728Phase 3

Hyperbaric Oxygen Therapy in HAMstring Injury (HOTHAM) Trial

Recruiting
NCT05804097Phase 4

Does Increasing Oxygen Nurture Your Symptomatic Ischemic Ulcer Sufficiently?

Active Not Recruiting
NCT05343754Phase 3

Hyperbaric Oxygen Therapy for Pyoderma Gangrenosum

Terminated
NCT04842448Phase 2

Safety and Efficacy of Hyperbaric Oxygen Therapy for Long COVID Syndrome

Completed
NCT04664790Not Applicable

Hyperbaric Oxygen Therapy Compared to Cognitive Training in FASD

Not Yet Recruiting
NCT04261738Not Applicable

Effects of HBO on Glucose in Patients With DM

Suspended
NCT06267300Phase 3

Treatment of Post-COVID-19 With Hyperbaric Oxygen Therapy: a Randomized, Controlled Trial

Not Yet Recruiting
NCT01828190Not Applicable

The Influence of Hyperbaric Oxygen in Patients With Perianal Crohn's Disease Already Treated With TNF Alpha Blockers Treated With TNF Alpha Blockers

Completed
NCT04297358Phase 4

Hyperbaric Oxygen in Patients Who Had a Stroke

Completed
NCT04327505Phase 2

Safety and Efficacy of Hyperbaric Oxygen for ARDS in Patients With COVID-19

Terminated

Drug Details

Intervention Type
DEVICE
Total Trials
52